5th February 2021 | EXAS - EXACT Sciences Corp. | 17,543 | Exercise of derivative | 777,153 | $5.70 | $99,995.10 | $4,429,772.10 |
1st February 2021 | EXAS - EXACT Sciences Corp. | 30,344 | Open or private sale10b5-1 trading plan | 759,610 | $138.07 | $4,189,596.08 | $104,879,352.70 |
28th December 2020 | EXAS - EXACT Sciences Corp. | 35,750 | Bona fide gift | 789,954 | $0.00 | | |
4th January 2021 | EXAS - EXACT Sciences Corp. | 31,814 | Open or private sale10b5-1 trading plan | 825,704 | $128.74 | $4,095,734.36 | $106,301,132.96 |
31st December 2020 | EPZM - Epizyme, Inc. | 1,024 | Grant/award etc. | 9,559 | $10.86 | $11,120.64 | $103,810.74 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 100 | Open or private sale10b5-1 trading plan | 857,518 | $126.59 | $12,659.00 | $108,553,203.62 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 100 | Open or private sale10b5-1 trading plan | 857,618 | $126.49 | $12,649.00 | $108,480,100.82 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 7,043 | Open or private sale10b5-1 trading plan | 857,718 | $125.92 | $886,854.56 | $108,003,850.56 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 10,840 | Open or private sale10b5-1 trading plan | 864,761 | $124.88 | $1,353,699.20 | $107,991,353.68 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 7,776 | Open or private sale10b5-1 trading plan | 875,601 | $124.03 | $964,457.28 | $108,600,792.03 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 2,918 | Open or private sale10b5-1 trading plan | 883,377 | $122.91 | $358,651.38 | $108,575,867.07 |
1st December 2020 | EXAS - EXACT Sciences Corp. | 1,800 | Open or private sale10b5-1 trading plan | 886,295 | $122.05 | $219,690.00 | $108,172,304.75 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 400 | Open or private sale10b5-1 trading plan | 888,095 | $124.71 | $49,884.00 | $110,754,327.45 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 600 | Open or private sale10b5-1 trading plan | 888,495 | $123.45 | $74,070.00 | $109,684,707.75 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 9,577 | Open or private sale10b5-1 trading plan | 889,095 | $122.33 | $1,171,554.41 | $108,762,991.35 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 10,229 | Open or private sale10b5-1 trading plan | 898,672 | $121.52 | $1,243,028.08 | $109,206,621.44 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 6,512 | Open or private sale10b5-1 trading plan | 908,901 | $120.45 | $784,370.40 | $109,477,125.45 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 1,108 | Open or private sale10b5-1 trading plan | 915,413 | $119.18 | $132,051.44 | $109,098,921.34 |
2nd November 2020 | EXAS - EXACT Sciences Corp. | 4,393 | Open or private sale10b5-1 trading plan | 916,521 | $118.32 | $519,779.76 | $108,442,764.72 |
1st October 2020 | EXAS - EXACT Sciences Corp. | 1,136 | Open or private sale10b5-1 trading plan | 920,914 | $105.20 | $119,507.20 | $96,880,152.80 |
1st October 2020 | EXAS - EXACT Sciences Corp. | 5,200 | Open or private sale10b5-1 trading plan | 922,050 | $104.70 | $544,440.00 | $96,538,635.00 |
1st October 2020 | EXAS - EXACT Sciences Corp. | 9,391 | Open or private sale10b5-1 trading plan | 927,250 | $103.57 | $972,625.87 | $96,035,282.50 |
1st October 2020 | EXAS - EXACT Sciences Corp. | 11,698 | Open or private sale10b5-1 trading plan | 936,641 | $102.86 | $1,203,256.28 | $96,342,893.26 |
30th September 2020 | EPZM - Epizyme, Inc. | 933 | Grant/award etc. | 8,535 | $11.93 | $11,130.69 | $101,822.55 |
25th January 2019 | EXAS - EXACT Sciences Corp. | 23,236 | Open or private sale | 886,011 | $82.49 | $1,916,667.93 | $73,084,389.36 |
25th January 2019 | EXAS - EXACT Sciences Corp. | 181,250 | Open or private sale | 909,247 | $81.90 | $14,844,193.75 | $74,466,420.05 |
25th January 2019 | EXAS - EXACT Sciences Corp. | 36,453 | Open or private sale | 1,090,497 | $80.78 | $2,944,782.70 | $88,093,619.15 |
25th January 2019 | EXAS - EXACT Sciences Corp. | 28,605 | Open or private sale | 1,126,950 | $79.89 | $2,285,339.27 | $90,035,416.35 |
25th January 2019 | EXAS - EXACT Sciences Corp. | 34,853 | Open or private sale | 1,155,555 | $78.80 | $2,746,416.40 | $91,057,734.00 |
24th January 2019 | EXAS - EXACT Sciences Corp. | 304,397 | Exercise of derivative | 1,190,408 | $0.00 | | |
25th February 2019 | EXAS - EXACT Sciences Corp. | 16,400 | Open or private sale | 903,936 | $90.55 | $1,485,036.40 | $81,852,308.74 |
23rd February 2019 | EXAS - EXACT Sciences Corp. | 34,325 | Exercise of derivative | 920,336 | $0.00 | | |
27th February 2019 | EXAS - EXACT Sciences Corp. | 20,575 | Exercise of derivative | 935,367 | $0.00 | | |
27th February 2019 | EXAS - EXACT Sciences Corp. | 9,169 | Open or private sale | 914,792 | $95.07 | $871,733.51 | $86,972,934.61 |
26th February 2019 | EXAS - EXACT Sciences Corp. | 20,025 | Exercise of derivative | 923,961 | $0.00 | | |
28th February 2019 | EXAS - EXACT Sciences Corp. | 10,014 | Open or private sale | 925,353 | $93.20 | $933,344.86 | $86,246,601.01 |
11th March 2019 | EXAS - EXACT Sciences Corp. | 11,227 | Open or private sale | 938,526 | $87.21 | $979,129.12 | $81,850,729.51 |
9th March 2019 | EXAS - EXACT Sciences Corp. | 24,400 | Exercise of derivative | 949,753 | $0.00 | | |
31st March 2019 | EPZM - Epizyme, Inc. | 897 | Grant/award etc. | 3,775 | $12.39 | $11,113.83 | $46,772.25 |
30th June 2019 | EPZM - Epizyme, Inc. | 887 | Grant/award etc. | 4,662 | $12.55 | $11,131.85 | $58,508.10 |
16th December 2019 | EXAS - EXACT Sciences Corp. | 4,277 | Exercise of derivative | 950,466 | $23.38 | $99,996.26 | $22,221,895.08 |
16th December 2019 | EXAS - EXACT Sciences Corp. | 7,163 | Exercise of derivative | 946,189 | $13.96 | $99,995.48 | $13,208,798.44 |
30th April 2019 | EXAS - EXACT Sciences Corp. | 500 | Grant/award etc. | 939,026 | $42.44 | $21,220.00 | $39,852,263.44 |
30th September 2019 | EPZM - Epizyme, Inc. | 1,078 | Grant/award etc. | 5,740 | $10.32 | $11,124.96 | $59,236.80 |
25th February 2020 | EXAS - EXACT Sciences Corp. | 18,115 | Open or private sale | 966,676 | $85.11 | $1,541,767.65 | $82,273,794.36 |
24th February 2020 | EXAS - EXACT Sciences Corp. | 34,325 | Exercise of derivative | 984,791 | $0.00 | | |
27th February 2020 | EXAS - EXACT Sciences Corp. | 13,875 | Open or private sale | 982,138 | $80.27 | $1,113,746.25 | $78,836,217.26 |
26th February 2020 | EXAS - EXACT Sciences Corp. | 9,312 | Exercise of derivative | 996,013 | $0.00 | | |
26th February 2020 | EXAS - EXACT Sciences Corp. | 20,025 | Exercise of derivative | 986,701 | $0.00 | | |
28th February 2020 | EXAS - EXACT Sciences Corp. | 9,750 | Open or private sale | 992,963 | $80.17 | $781,657.50 | $79,605,843.71 |
27th February 2020 | EXAS - EXACT Sciences Corp. | 20,575 | Exercise of derivative | 1,002,713 | $0.00 | | |
31st December 2019 | EPZM - Epizyme, Inc. | 452 | Grant/award etc. | 6,192 | $24.60 | $11,119.20 | $152,323.20 |
31st March 2020 | EPZM - Epizyme, Inc. | 717 | Grant/award etc. | 6,909 | $15.51 | $11,120.67 | $107,158.59 |
3rd August 2020 | EXAS - EXACT Sciences Corp. | 198 | Open or private sale | 968,266 | $95.00 | $18,810.00 | $91,985,270.00 |
3rd August 2020 | EXAS - EXACT Sciences Corp. | 25,000 | Open or private sale | 968,464 | $93.79 | $2,344,750.00 | $90,832,238.56 |
30th April 2020 | EXAS - EXACT Sciences Corp. | 501 | Grant/award etc. | 993,464 | $42.44 | $21,262.44 | $42,162,612.16 |
1st September 2020 | EXAS - EXACT Sciences Corp. | 19,927 | Open or private sale | 948,339 | $75.03 | $1,495,122.81 | $71,153,875.17 |
30th June 2020 | EPZM - Epizyme, Inc. | 693 | Grant/award etc. | 7,602 | $16.06 | $11,129.58 | $122,088.12 |